Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Sandu Pharmaceuticals Ltd.

Sandu Pharmaceutical

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
10 06 2021 Inter alia, to consider the following 1. To consider and take note of the said demise of Shri Bhaskar G Sandu (DIN:02816792), Chairman of our company. 2. To consider and recommend appointment of Statutory Auditor 3. Any other matter with the permission of Chairman.
30 06 2021 Audited Results
14 08 2021 Quarterly Results & Dividend
13 11 2021 Quarterly Results
29 11 2021 Inter alia, to consider and approve Appointment of Internal Auditor for Mumbai at its Corporate Office
14 02 2022 Quarterly Results
30 05 2022 Audited Results
07 07 2022 Inter alia, to consider and approve : 1. To Consider and Reappoint CMA Shekhar Joshi & Co, Cost Accountants (Registration No. 100448) as Cost Auditor of the Company for the Financial Year 2022-23. 2. To Consider/Approve/Discuss on 03RD and Final Tranche, conversion of 8,50,326 nos of Equity Warrants Conversion into Equity Shares. 3. Any other matter.
12 08 2022 Quarterly Results & Dividend
14 11 2022 Quarterly Results
14 02 2023 Quarterly Results
30 05 2023 Audited Results
14 08 2023 Quarterly Results & Final Dividend
13 11 2023 Quarterly Results
14 02 2024 Quarterly Results
30 03 2024 Inter alia, to consider and approve: - 1. To Consider and Appoint Chief Financial Officer of the Company. 2. Any other matter with the permission of Chairman.
14 11 2024 Quarterly Results
13 02 2025 Quarterly Results
28 05 2025 Final Dividend & Audited Results
13 08 2025 Quarterly Results
14 10 2025 Inter alia, to consider the following :- 1. To Approve Notice of Postal Ballot for reclassification of M/s Akshath Finvest and Properties Private Limited from Promoter/ Promoter Group category to Public category pursuant to NOC received from Bombay Stock Exchange Limited dated 26 September 2025. 2. Any other matter with the permission of Chairman.
12 11 2025 Quarterly Results
06 02 2026 Quarterly Results
05 05 2026 Final Dividend & Audited Results

News

12-DEC-2022

Sandu Pharmaceuticals inks MoU with Bach Ma Van Xuan Pharmaceuticals

The purpose of this MOU is to further business relationship and to broaden the scope between two Companies in Vietnam and India

09:47 AM
Enrich money logo